Wednesday, June 16, 2021 10:52:03 PM
All biotech companies and clinical trials refer to non-FDA approved compounds intended to treat or prevent illness as drugs.
This is a fact.
There really is nothing to argue.
I could give thousands of examples of non-FDA approved investigational compounds being called drugs.
Here's one:
https://www.bloomberg.com/news/articles/2021-05-13/alzheimer-s-drug-biogen-hopes-controversial-aducanumab-gets-fda-approval
NNVC's any my use of the word drug for the nanoviricide compounds NNVC is developing is consistent with industry standards.
Arguing otherwise is just silly and wrong, although my stating the obvious sadly will not stop any of the continuing silliness and ignorant punditry.
Here, take it from the FDA about investigational drugs. How could anyone believe or argue otherwise?
https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/understanding-investigational-drugs
Yes, even preclinical compounds are called "drugs!"
https://bmcneurol.biomedcentral.com/articles/10.1186/1471-2377-9-S1-S2
Here is the FDA:
https://www.fda.gov/patients/drug-development-process/step-2-preclinical-research
I believe a phrase such as "my word" or equivalent is appropriate to express the level of disbelief for any argument against the use of the word drug for investigational compounds.
Truly unbelievable that anyone thinks that the compounds NNVC is developing should not be called drugs.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM